SPERO

SPERO – healthcare technology company which is engaged in improvement of the efficiency of the infertility treatment by means of an IVF up to 2.5 times in comparison with standard procedures. Such high performance is achieved by calculating the exact procedure date based on machine learning and using big data analysis, in addition to standardization, automation and clarification of the treatment through a blockchain platform. The calculation of a procedure date is based on a clinical picture of the couple, the hormonal background of the woman as well as the laboratory tests results. The calculation of the most favorable date of IVF along with an accurate abidance by the protocols of preparation and implementation of the IVF can increase the probability of success from an average 30% up to 65-75%.